Source link : https://www.newshealth.biz/health-news/novel-treatment-appears-to-show-benefit-in-als/
DENVER — A novel treatment candidate for amyotrophic lateral sclerosis (ALS) met its primary safety and secondary endpoints in the phase IIb PARADIGM trial. ALS patients treated with PrimeC — a formulation of two FDA-approved drugs, ciprofloxacin and celecoxib — had similar safety outcomes as those treated with placebo, reported Merit Cudkowicz, MD, MSc, of […]
Author : News Health
Publish date : 2024-04-18 21:13:15
Copyright for syndicated content belongs to the linked Source.